Biotech firm BeiGene slides in Shanghai debut after $3.5b STAR Market IPO

Biotech firm BeiGene slides in Shanghai debut after $3.5b STAR Market IPO

Stock information is displayed on an electronic board at a securities brokerage in Shanghai, Chin. Photographer: Qilai Shen/Bloomberg

Reuters

16 December, 2021

BeiGene

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

You may also like

Read more from Greater China

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.